Skip to main content

Table 3 Prices (per unit) for 12 active ingredients in Austrian hospitals and in out-patient care

From: The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices

Active ingredient

O/G1

Hospitals (n = 5 unless otherwise specified), range

Out-patient sector

Official list price2

Actual hospital price3

Pharmacy retail price net4

Reimbursement price5

Prices as of 30 September 2009

Oncology

Trastuzumab 150 mg powder for concentrate for solution f. infusion

O

690.-

690.- – 713.81

932.18

748.60

Docetaxel 1 × 2 ml 80 mg/2 ml concentrate and solvent for solution for infusion

O

654.06

622.90 – 663.67

885.68

711.30

Rituximab 500 mg concentrate and solvent for solution for infusion

O

1516.43

1516.43

2001.36

1607.30

Imatinib 400 mg tablets (30 tabs)

O

84.87

84.87 (n = 4)

111.12

89.24

Cardiology

Amlodipin 5 mg tablets (28 units)

O

0.29

0.00 (n = 4)

0.55

0.44

Amlodipin 5 mg tablets (28 units)

G

0.20

0.00 (n = 1)

0.41

0.32

Simvastatin 20 mg tablets (30 units)

G1

0.26

0.00 (n = 2)

0.49

0.40

Simvastatin 20 mg tablets (30 units)

G2

0.23

0.00 (n = 3)

0.45

0.40

Atorvastatin 20 mg tablets (30 units)

O

1.10

0.00

1.94

1.56

Rheumatoid arthritis

Etanercept 1 ml (50 mg/ml) solution for injection in a prefilled pen

O

242.53

242.53 (n = 2)

323.65

259.93

Immunomodulation

Immunoglobulin 100 mg/ml, solution for injection in vial (50 ml)

G1

246.18

185.- – 190.- (n = 4)

348.36

279.20

Immunoglobulin

100 mg/ml, solution for injection in vial (50 ml)

G2

219.40

160.- – 185.-

310.45

248.85

Anti-inflammatory

Infliximab 100 mg powder for concentrate for solution for infusion

O

565.50

565.50 (n = 4)

762.32

612.20

Neurology-multiple sclerosis

Interferon beta-1α 1 × 0.5 ml (44 mcg/0.5 ml) solution for injection – prefilled pen

O

81.25

81.25 (n = 3)

107.68

86.48

Blood

Clopidogrel 75 mg tablets (28 units)

O

1.64

1.64 – 1.71

2.90

2.32

  1. 1O original product, G generic; in case of more than one generic, numbering of the generics (G1, G2).
  2. 2 Equals the ex-factory price for out-patient medicines. No range, as this is the same in all hospitals.
  3. 3 The (actual) price or amount paid by a hospital (or hospital pharmacy) in order to take delivery of certain unit of medicines. The price excludes the value added tax (VAT).
  4. 4 The price charged by retail pharmacies to the general public. It includes any pharmacy mark-up or dispensing fee. The net price excludes VAT.
  5. 5 Reimbursement price paid by Austrian sickness funds, called “Kassenpreis”. However, seven of the selected products are not included in the out-patient reimbursement list (“Erstattungskodex”, EKO). Therefore the indicated out-patient prices are rather of theoretic character.
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us